and the 4Rheumatic Diseases Centre, University of Manchester, Manchester SUMMARY Parotid and submandibular gland secretions collected from patients with rheumatoid arthritis or systemic sclerosis have been analysed and the results compared with those obtained from a matched group of healthy individuals. Flow rates were measured and the saliva samples assayed for amylase, kallikrein, protein, and salivary IgA concentration. The results showed that only patients with rheumatoid arthritis had a reduced salivary flow, especially parotid flow, with a significantly increased concentration of salivary IgA in both parotid and submandibular saliva. Patients with systemic sclerosis did not show significantly altered salivary flow rates, but there was a marked depletion of salivary IgA content in both parotid and submandibular saliva. Neither disease states appeared to alter the kallikrein or amylase content of saliva. The possible clinical value of these findings is discussed.
A complication of connective tissue disease is secretory failure of the lacrimal and salivary glands, which leads to dry eyes and dry mouth. The duct cells of these exocrine glands store kallikrein.' 2 Consequently, measurement of the kallikrein content of saliva could be a sensitive measure of duct damage in patients with connective tissue disease, in which the gland ducts are known to be invaded by lymphocytes and plasma cells.
This study compares the secretion parameters of kallikrein and other compounds in patients who have either rheumatoid arthritis or systemic sclerosis with those obtained from a sex and age matched group of healthy control subjects.
Materials and methods
Current diagnostic criteria for rheumatoid arthritis3 and systemic sclerosis4 were used. The study was performed on 20 unselected patients with definite or classical rheumatoid arthritis and 26 unselected patients with systemic sclerosis. Of the 20 rheumaAccepted for publication 5 June 1984. Correspondence to R W Matthews. toid patients 15 As deficient quantity and quality of saliva is the direct cause of symptoms, measurement of both has importance in this study. Flow rate estimations from the parotid and submandibular glands has the disadvantage of examining secretions from only one group of glands and ignores the significant contributions made by the minor glands. The amount of saliva collected is influenced by many factors including age, sex, time of day, size of secreting gland, and the technique of saliva collection.
The method of collection for this study was designed to overcome access difficulties encountered in the systemic sclerosis patients who had very limited mouth opening due to the nature of their disease. Parotid saliva was relatively easier to collect than submandibular saliva using the described technique and it is likely that not every fraction of a millilitre was collected from a duct opening during the timed period. However, the results of salivary flow rate from the parotid gland of healthy subjects group.bmj.com on July 7, 2017 -Published by http://ard.bmj.com/ Downloaded from years, and the larger number of patients screened in this study makes the present findings relevant, and is in accordance with more recent observations. '9 A study on whole saliva20 as well as a study on separate parotid and submandibular saliva2' showed that salivary flow and IgA content have an inverse relationship, that is, as salivary flow increases the salivary IgA falls. However, it does not follow that a raised IgA would be expected in saliva from patients with reduced salivary flow. It could be that in immunologically damaged glands of patients with rheumatoid arthritis the transport and secretion mechanism of IgA is intact, whereas in the damaged glands of patients with systemic sclerosis it is not.
Both amylase and kallikrein levels in saliva showed no significant changes in rheumatoid arthritis or systemic sclerosis. As the majority of patients were female and postmenopausal, any possible hormonal effect on kallikrein secretion was thought to be small, especially as the samples were collected in the afternoon when the female hormone effect is minimal. 15 Since the total protein in submandibular saliva of systemic sclerosis patients was significantly reduced, and there was no change in the kallikrein or amylase level of the same saliva, it seems that it is the IgA which is preferentially depleted from saliva in systemic sclerosis. The mechanism of this selectivity is unknown.
Parotid salivary flow rates measured in this study were significantly reduced in those patients with rheumatoid arthritis, and this confirms previous findings.'2 The lack of significant decrease in salivary flow from parotid or submandibular glands of patients with systemic sclerosis is at variance with other reports.
It is possible that exocrine gland failure in systemic sclerosis, when it occurs, is primarily due to fibrosis and collagen deposition within the glands rather than immune inflammatory damage such as occurs in rheumatoid arthritis and that the latter causes earlier gland damage. Subjective assessment of xerostomia showed that patients with systemic sclerosis were more likely to have symptoms of dry mouth than controls but not so frequently as patients with rheumatoid arthritis. In the latter group the symptoms were confirmed as being related to deficiency of salivary flow, but in the systemic sclerosis group such a relationship was not confirmed statistically.
Therefore this study has shown that patients with systemic sclerosis have a significantly reduced salivary IgA level as estimated from human serum as standard, and rheumatoid patients were 
